Sly Saint
Senior Member (Voting Rights)
from Introduction
full paper here
https://bmjopen.bmj.com/content/bmjopen/9/2/e024622.full.pdf
RA
is defined as ‘the belief in superiority of an
intervention and of the superior validity of
the theory of change that is associated with
the treatment’1 (p. 55).
Abstract
Introduction One potential source of bias in randomised
clinical trials of psychological interventions is researcher
allegiance (RA). The operationalisation of RA differs
strongly across studies, and there is not a generally
accepted method of operationalising or measuring it.
Furthermore, it remains unclear as to how RA affects the
outcomes of trials and if it results in better outcomes
for a preferred intervention. The aim of this project is to
develop and validate a scale that accurately identifies RA,
contribute to the understanding of the impact that RA has
in a research setting and to make recommendations for
addressing RA in practice.
Methods and analysis
A scale will first be developed and
validated to measure RA in psychotherapy trials. The scale
will be validated by surveying authors of psychotherapy
trials to assess their opinions, beliefs and preferences of
psychotherapy interventions. Furthermore, the scale will
be validated for use outside the field of psychotherapy.
The validated checklist will then be used to examine two
potential mechanisms of how RA may affect outcomes
of interventions: publication bias (by assessing grants)
and risk of bias (RoB). Finally, recommendations will be
developed, and a feasibility study will be conducted at a
national mental health agency in The Netherlands. Main
analyses comprise inter-rater reliability of checklist items,
correlations to examine the relationship between checklist
items and author survey (convergent validity) as well as
checklist items and trial outcomes and multivariate meta-
regression techniques to assess potential mechanisms of
how allegiance affects trial outcomes (publication bias and
RoB).
interesting, a nice twist perhaps(?) But will anyone use it? Cochrane seem to be going in the opposite direction.this study will contribute to the
development of clinical trial guidelines and enhance the
field of psychotherapy research and practice. Once a valid
method exists to measure RA, future research should be
devoted to further studying different mechanisms of bias
(ie, quality of delivered therapy and control conditions
in clinical trials) and the associated relationship with RA.
full paper here
https://bmjopen.bmj.com/content/bmjopen/9/2/e024622.full.pdf
Last edited: